German China

USA: Spectroscopic Instruments Agilent Technologies Acquires Spectroscopy Producer Cobalt

Editor: MA Alexander Stark

Agilent Technologies has acquired Cobalt Light Systems, a provider of highly differentiated Raman spectroscopic instruments for the pharmaceutical industry, applied markets and public safety.

Related Vendor

Agilent Technologies Acquires Raman Spectroscopy Innovator, Cobalt Light Systems
Agilent Technologies Acquires Raman Spectroscopy Innovator, Cobalt Light Systems
(Source: Pixabay)

Santa Clara/USA — Cobalt’s benchtop and handheld/portable Raman spectroscopic instruments are based on proprietary technologies that enable through-barrier identification of chemicals and materials. By enabling measurement through opaque barriers and surfaces, the company’s solutions can analyze whole tablets or inside sealed containers reducing the need for quarantines and time-consuming sample processing and testing in pharmaceutical QC, hazardous chemical ID and security. Recently, the manufacturer has entered the hazardous substances markets with its handheld platform.

“Raman spectroscopy is one of the fastest-growing segments in spectroscopy,” said Phil Binns, vice president and general manager of Agilent’s Spectroscopy and Vacuum Solutions Division. “This acquisition gives our customers access to state-of-the-art Raman spectroscopy technology. It also provides Agilent immediate entry into this fast-growing segment with a highly competitive, differentiated offering.”

Agilent is acquiring Cobalt for $ 51,85 million in cash.

According to the company, Cobalt’s CEO will remain with Agilent as the Director of Raman Spectroscopy. Oxford will become Agilent’s global center for Raman spectroscopy.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent

(ID:44784368)